Founder of 5 different companies, among them: Kura Oncology, Inc., Avidity Biosciences, Inc. and Ambrx, Inc. Troy E. Wilson is an entrepreneur and businessperson who has been at the head of 9 different companies and currently is Non-Executive Chairman for Avidity Biosciences, Inc. (which he founded in 2012), Chairman, President, CEO & Chief Financial Officer at Kura Oncology, Inc. (which he founded in 2014), Executive Chairman of Wellspring Biosciences LLC, Executive Chairman at Abintus Bio, Inc. and Managing Member at Araxes Pharma LLC.

He is also on the board of Puma Biotechnology, Inc.

Troy E. Wilson previously occupied the position of President of Wildcat Discovery Technologies, Inc. (he founded the company), Founding Partner of Presidio Partners, Chairman, President & Chief Executive Officer for Zeta Acquisition Corp. III, President, Chief Executive Officer & Director at Intellikine LLC (he founded the company in 2007), Chief Executive Officer of Takeda Pharmaceuticals U.S.A., Inc., Chief Business Officer at Ambrx, Inc. (he founded the company in 2003) and Vice President-Business Development at Novartis Institute for Functional Genomics, Inc.

Dr. Wilson received a doctorate and an undergraduate degree from the University of California, Berkeley and a graduate degree from New York University.